30th Annual CBB Conference
"Frontiers in Biocatalytic Science"
October 14, 2023
The University of Iowa
Pharmacy Building, Iowa City, IA
Saturday, October 14, 2023 – Pharmacy Building, 180 South Grand Avenue
7:30 – 8:15 am—Registration – CPB Atrium
7:30 – 8:15—Continental Breakfast – CPB Atrium
8:15 – 8:30—Program-210 CPB
Introduction and welcome:
Mark A. Arnold, Ph.D., Director, Center for Biocatalysis and Bioprocessing; Edwin B. Green Chair Professor in Laser Chemistry, Department of Chemistry, College of Liberal Arts and Sciences, The University of Iowa, Iowa City, IA
Aliasger Salem, Ph.D., Lyle and Sharon Bighley Chair in Pharmaceutical Science, College of Pharmacy; Associate Vice President for Research, The University of Iowa, Iowa City, IA
8:30 – 9:15—MULTIPLE APPLICATIONS OF QPCR FOR MICROBIAL CFU EVALUATION AND IDENTIFICATION
Edgar Valencia-Morales, Ph.D., Microbial Viability Lab Lead, Bayer's Crop Sciences Division Chesterfield, MO
9:15 – 10:00—LIGHT-BASED MANUFACTURING IN RETINAL ENGINEERING: FUNDAMENTALS, CONSTRAINTS, AND CONSIDERATIONS FOR CELL DELIVERY SCAFFOLDS AND IN VITRO MODELS
Kristan S. Worthington, Ph.D., Associate Professor of Biomedical Engineering, Roy J. Carver Department of Biomedical Engineering, The University of Iowa, Iowa City, IA
10:00 – 10:15—Break-CPB110 Atrium
10:15 – 11:00—POLYSACCHARIDE DEGRADATION IN THE HUMAN GUT AND ITS POTENTIAL APPLICATIONS IN BIOTECHNOLOGY AND HUMAN HEALTH
Isaac Cann Ph.D., Professor, Department of Animal Sciences, Division of Nutritional Sciences, Center for East Asian and Pacific Studies and the Carl R. Woese Institute for Genomic Biology University of Illinois Urbana-Champaign (UIUC), Urbana, ILL
11:00 – 11:45—MOVING FROM AN ACADEMIA TO A COMMERCIAL VENTURE: WHEN IS THE TIME RIGHT?
Melissa Bates, Ph.D., FAPS, Adjunct Associate Professor of Internal Medicine, The University of Iowa and Founder and CEO, LSF Medical Solutions, Iowa City, IA
11:45 – 12:00 pm—Relocation to CPB Atrium
12:00 – 12:45—Lunch- poster session 1 (odd numbers)
12:45 – 1:30—Lunch- poster session 2 (even numbers)
Afternoon Session – 210 CPB
1:45 – 2:30—EMBRACING ENTREPRENEURSHIP IN ACADEMIA: THE THRILLING JOURNEY FROM SCIENTIFIC DISCOVERY TO CLINICAL INNOVATION
Arnon Lavie, Ph.D., Professor, Department of Biochemistry and Molecular Genetics College of Medicine, University of Illinois at Chicago, Chicago, Ill and Co-founder and CEO, Enzyme by Design Inc, Chicago, ILL
2:30 – 3:10—NIH/CBB Fellow Presentations
INSULATED-MEDIATED GLU4 TRANSLOCATION VIA SMALL MOLECULE BINDING OF UNC119 FOR THE TREATMENT OF DIABETES MELLITUS
Autumn Moore, Ph.D., was part of Robert Kern’s Research Group, Department of Pharmaceuticals, Medicinal and Natural Chemistry, College of Pharmacy, The University of Iowa, Iowa City, IA
THE ATAC HISTONE ACETYLTRANSFERASE COMPLEX IS A KEY ONCOGENIC DRIVER IN SARCOMAS
Souradip Sinha, Ph.D. candidate, Munir Tanas's Research Group, Department of Pathology, College of Medicine, The University of Iowa, Iowa City, IA
3:10 - 3:30— Poster Awards and closing remarks
3:30 — Adjourn